Loteprednol Etabonate Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Clinical trial NCT02208297 · COMPLETED

Trial details

NCT number: NCT02208297
Sponsor: Bausch & Lomb Incorporated
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Inflammation Pain Cataract

Start date: 2014-09-01
Primary completion: 2015-03-01
Enrollment: 326

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.